NRx Defense Systems wins initial $11.18 million DARPA prime contract for SPARC-TMS depression trialPUBT·Oct 5, 2026 at 09:01 PMNRXP-1.02%
Ascendiant Capital maintains Buy rating on NRX Pharmaceuticals, $50 price targetTradingView·Oct 1, 2026 at 09:21 AMNRXP-1.02%
NRX Pharmaceuticals (NRXP) Receives a Rating Update from a Top AnalystTip Ranks·Sep 22, 2026 at 09:46 AMNRXP-1.02%
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free KetamineGlobeNewswire·Sep 15, 2026 at 07:11 PMNRXP-1.02%
NRx Pharma unit GeNeuro wins European patent for ALS antibody candidate GNK-301PUBT·Sep 14, 2026 at 11:04 AMNRXP-1.02%
NRx Pharma to present at Moody Capital Solutions Disruptive Growth & Life Sciences ConferencePUBT·Sep 8, 2026 at 11:06 AMNRXP-1.02%MCO-0.55%
Global Crosscurrents and Macro Shifts Fragment US Thematic Equities in 2026Global Report·Sep 3, 2026 at 10:12 AMCRESY-3.96%ABEV-1.24%
NRX Pharmaceuticals reports $18.0M net loss for first half 2026, $26.7M cash on handTradingView·Aug 17, 2026 at 12:03 PMNRXP-1.02%
